| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.044 | 0.3 |